The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of taxane platinum doublet chemotherapy with triple oral metronomic chemotherapy and low dose nivolumab as neoadjuvant therapy in locally advanced head and neck squamous cell carcinoma.
 
Shriraj Talati
No Relationships to Disclose
 
Minit Shah
No Relationships to Disclose
 
Vanita Noronha
Research Funding - AstraZeneca (Inst); Johnson & Johnson/Janssen (Inst); Merck (Inst); Nanobiotix (Inst); Novartis (Inst); Roche India (Inst)
Travel, Accommodations, Expenses - American Society of Clinical Oncology
 
Nandini Menon
No Relationships to Disclose
 
Nivedita Chakrabarty
No Relationships to Disclose
 
Vijay Patil
Research Funding - AstraZeneca (Inst); Eisai Germany (Inst); Intas (Inst); Johnson & Johnson/Janssen (Inst); NATCO Pharma (Inst); Novartis (Inst)
 
Amit Janu
No Relationships to Disclose
 
Neha Mittal
No Relationships to Disclose
 
Munita Bal
No Relationships to Disclose
 
Kumar Prabhash
Research Funding - Alkem Laboratories (Inst); Aurigene Oncology Limited (Inst); BDR Pharmaceutics (Inst); Biocon (Inst); Dr. Reddy's Laboratories (Inst); Fresenius Kabi (Inst); Johnson and Johnson (Inst); NATCO Pharma (Inst); Roche (Inst)
 
Prajakta Dhanvijay
No Relationships to Disclose
 
Ankush Shetake
No Relationships to Disclose
 
Anupa John
No Relationships to Disclose
 
Anjali Shah
No Relationships to Disclose
 
Sneha Dhar
No Relationships to Disclose